Christopher G. Hayes - 11 Jul 2022 Form 4 Insider Report for Verrica Pharmaceuticals Inc. (VRCA)

Signature
/s/ Mark Ballantyne, Attorney-in-Fact
Issuer symbol
VRCA
Transactions as of
11 Jul 2022
Net transactions value
+$25,500
Form type
4
Filing time
11 Jul 2022, 17:24:11 UTC
Previous filing
05 Jul 2022
Next filing
03 Mar 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction VRCA Common Stock Purchase $25,500 +7,500 +91% $3.40 15,714 11 Jul 2022 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.